ClinConnect ClinConnect Logo
Search / Trial NCT07025187

the Effect of Integrated Neuomuscular Inhibition Technique on Adult Females With Cervicogenic Headache

Launched by KAFRELSHEIKH UNIVERSITY · Jun 9, 2025

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying whether a special treatment called the integrated neuromuscular inhibition technique can help adult women who suffer from cervicogenic headaches—headaches that start from problems in the neck. The study will include 40 women who have been diagnosed with this type of headache by a neurologist and who meet certain conditions, like having headaches at least once a week for three months or more, and specific neck issues that can be felt during an exam.

Participants will be randomly placed into two groups. Both groups will receive the usual medical care for their headaches, but one group will also get the integrated neuromuscular inhibition technique, which is a hands-on therapy aimed at relaxing tight muscles and reducing pain. The study is not yet recruiting participants, and women between 18 and 60 years old who meet the criteria may be eligible. This trial could provide helpful information about new ways to relieve cervicogenic headaches using this additional therapy.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1 - A diagnosis of CGH will be made by an experienced neurologist as per the International Classification of Headache Disorders 3rd edition (ICHD-3) , but not including occipital nerve blockage 2-Additional inclusion criteria will include female patients aged\> 18 years and\<60 years.
  • 3-headache intensity ≥ 3 on eleven-point numerical rating scale at enrolment. 4-at least three-month history of headache with a mean frequency of \> 1/week. 5-hypomobility of the upper cervical spine (C0 to C3) on manual examination; and reproduction of the headache on palpation of the upper cervical spine (C0 to C3).
  • 6-In addition, patients should exhibit active trigger points within the suboccipital, and upper trapezius muscles, ipsilaterally over the symptomatic side reproducing their headache symptoms .
  • Exclusion Criteria:
  • * Patients will be excluded if they have any of the following:
  • 1. cervical radiculopathy,
  • 2. history of neck, shoulder trauma or surgery,
  • 3. history of intervention for head or neck pain within the previous 3 months,
  • 4. A diagnosis of other types of headaches using the criteria of ICHD-3.

About Kafrelsheikh University

Kafrelsheikh University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that contribute to the enhancement of healthcare practices and patient outcomes. With a strong emphasis on interdisciplinary collaboration, the university harnesses its diverse expertise in medical sciences, engineering, and technology to conduct rigorous clinical studies. Kafrelsheikh University aims to foster innovation in clinical research, ensuring compliance with ethical standards and regulatory requirements, while actively engaging in community health initiatives to address pressing health challenges. Through its commitment to excellence, the university seeks to develop evidence-based solutions that improve health and well-being at both local and global levels.

Locations

Tanta, Algharbia, Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported